Collectively, these results suggest that the enhanced colitis-associated tumorigenesis caused by Phd2 haplodeficiency is mediated, at least in part, by activation of the STAT3 and ERK1/2 signaling pathways in tumor cells through EREG. Here, MAPK3 is linked to colitis.